In addition, genetically-determined increases in NLRP3 inflammasome activity in humans or mice due to NLRP3 gain-of-function mutations are not usually associated with Crohn’s disease-like inflammation, possibly because in the presence of increased NLRP3 function, they are accompanied by activation of immune suppressor mechanisms (12). Here, NLRP3 is linked to Crohn disease.